Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
NYSE COMPOSITE INDX
Gold
Crude Oil
TESARO RG
(NQ:
TSRO
)
53.02
USD
+1.04 (+2.00%)
Official Closing Price
/ Updated:
8:00 PM EDT, Apr 24, 2018
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
901,933
Open
52.49
Bid (Size)
52.02 (100)
Ask (Size)
54.00 (100)
Prev. Close
51.98
Today's Range
52.08 - 53.82
52wk Range
50.67 - 168.92
Shares Outstanding
54,801,636
Dividend Yield
N/A
Performance
YTD
-29.89%
-29.89%
1 Month
-10.18%
-10.18%
3 Month
-27.30%
-27.30%
6 Month
-52.82%
-52.82%
1 Year
-61.34%
-61.34%
Top News
More News
TESARO Announces Positive Top-Line Results From Quadra Trial of ZEJULA®
April 24, 2018
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced results from the QUADRA study, which was designed to assess clinical benefit of ZEJULA® treatment in heavily...
Read More
from
GlobeNewswire News Releases
New Research Coverage Highlights MPLX LP, TESARO, LKQ, Cytokinetics, Keysight Technologies, and Charles River Laboratories International — Consolidated Revenues, Company Growth, and Expectations for 2
April 20, 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of MPLX LP (NYSE:MPLX),...
Read More
from
GlobeNewswire News Releases
More News
Read More
TESARO to Announce First-Quarter 2018 Financial Results on May 3, 2018
April 19, 2018
from
GlobeNewswire News Releases
TESARO Summarizes TSR-042 Clinical Data Presented at AACR
April 16, 2018
from
GlobeNewswire News Releases
Can This Smaller Biotech Actually Rival Merck, Bristol In Cancer Drugs?
April 16, 2018
from
Investor's Business Daily
TESARO and Medison Enter Into Exclusive Distribution Agreement to Commercialize ZEJULA® in Israel
April 11, 2018
from
GlobeNewswire News Releases
Clovis Pops After Ovarian Cancer Drug Gets FDA Win; Tesaro Topples
April 06, 2018
from
Investor's Business Daily
Tesaro Inc Has Returned 14.0% Since SmarTrend Recommendation (TSRO)
April 24, 2018
from
Comtex SmarTrend® News Briefs
Noteworthy Monday Option Activity: TSRO, ERI, WSM
April 16, 2018
category
Stocks
from
Market News Video
Tesaro Inc Shares Down 9.5% Since SmarTrend's Sell Call (TSRO)
April 17, 2018
from
Comtex SmarTrend® News Briefs
BRIEF-Tesaro Summarizes TSR-042 Clinical Data Presented At AACR
April 16, 2018
category
companyNews
from
Reuters: Company News
Stock Market JSON API
provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Six Financial